Related Experiment Video
Updated: Mar 3, 2026

A Porcine Model of Acute Autologous Pulmonary Embolism
Published on: September 6, 2024
Post-pulmonary embolism syndrome: a practical narrative review
Crhistian-Mario Oblitas1, Lucía Barrera-López1, Francisco Galeano-Valle2
1Instituto de Investigación Sanitaria de Santiago de Compostela, Spain; Departamento de Medicina Interna, Complejo Hospitalario Universitario de Santiago de Compostela, Spain.
Post-pulmonary embolism syndrome (PPES) can cause long-term issues like breathlessness, even without pulmonary hypertension. Early recognition of post-PE impairment (PPI) and chronic thromboembolic pulmonary hypertension (CTEPH) is crucial for better patient outcomes.
Area of Science:
- Cardiology
- Pulmonology
- Vascular Medicine
Background:
- Post-pulmonary embolism syndrome (PPES) encompasses long-term sequelae after acute pulmonary embolism (PE), often without overt pulmonary hypertension (PH) or right ventricular (RV) dysfunction.
- Persistent RV dysfunction affects up to 18% of patients post-PE, correlating with increased risk of recurrent venous thromboembolism (VTE) and mortality.
- The FOCUS study defined post-PE impairment (PPI) using RV dysfunction and clinical decline, identifying it as a predictor of adverse outcomes.
Purpose of the Study:
- To elucidate the spectrum of long-term sequelae following acute pulmonary embolism (PE).
- To define and characterize post-PE impairment (PPI) and its prognostic implications.
- To differentiate between chronic thromboembolic disease (CTED) and chronic thromboembolic pulmonary hypertension (CTEPH) and highlight management considerations.
Main Methods:
- Review of literature and clinical studies defining PPES, PPI, CTED, and CTEPH.
- Analysis of echocardiographic and clinical parameters to assess RV function and patient status.
- Examination of prognostic factors and treatment outcomes in patients with chronic thromboembolic disease.
Main Results:
- PPES includes persistent dyspnea, exercise intolerance, and psychological issues, with or without PH/RV abnormalities.
- Post-PE impairment (PPI), defined by RV dysfunction and clinical deterioration, predicts higher mortality, rehospitalization, and reduced quality of life.
- Chronic thromboembolic pulmonary hypertension (CTEPH) has a cumulative incidence of 0.5-4% within two years and is primarily driven by RV dysfunction.
Conclusions:
- Early identification and systematic follow-up of patients with PPES are essential.
- Advances in multimodal therapies for CTEPH have improved survival, emphasizing the need for timely diagnosis and intervention.
- Understanding the nuances between CTED and CTEPH is critical for appropriate patient management and prognosis.
Related Concept Videos
Pulmonary Embolism III: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism I: Introduction
Peripheral Artery Disease V: Postoperative Nursing Management
Venous Thrombosis IV: Nursing Management
Acute Coronary Syndrome V: Nursing Management

